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68* Renal cyst formation as tool for CFTR research
H. Li1, W. Yang1, F. Mendes2,3, M.D. Amaral2,3, D.N. Sheppard1. 1Physiology
and Pharmacology, University of Bristol, Bristol, United Kingdom; 2Chemistry
and Biochemistry, University of Lisboa, Lisboa, Portugal; 3Centre of Human
Genetics, National Institute of Health, Lisboa, Portugal
Madin Darby canine kidney (MDCK) epithelial cells are a valuable model sys-
tem to investigate renal cyst development and growth. These cells endogenously
express CFTR, form polarized epithelia on ﬁlter supports and cysts in collagen
gels. In previous work, we demonstrated that CFTR blockers retard cyst growth
predominantly by inhibiting ﬂuid accumulation within the cyst lumen (Li et al.
Kidney Int. 2004; 66:1926−38). Here, we investigate the utility of renal cysts for
CFTR research using MDCK cells stably expressing wild-type human CFTR (WT-
MDCK) or the most common CF mutation F508del (F508del-MDCK) and the
thiazolidinone CFTRinh-172, a potent, speciﬁc inhibitor of the CFTR Cl
− channel.
After 6 days growth in the continuous presence of forskolin (10mM), WT-MDCK
cells formed more cysts with larger volume compared to parental MDCK cells
(p< 0.01, Student’s unpaired t-test). By contrast, F508del-MDCK cells formed
fewer cysts with smaller volume (p< 0.05). CFTRinh-172 (10mM) reduced both the
number and volume of cysts formed by WT-MDCK cells (p< 0.01 vs. untreated
WT-MDCK). Because cyst enlargement is determined both by cell proliferation
and ﬂuid accumulation within the cyst lumen, we studied the proliferation of the
three MDCK cell lines with the same conditions used for cyst formation assays.
At day 6, no differences in cell numbers were observed (p> 0.05). Our ﬁnding that
either a loss-of-function mutation or a speciﬁc CFTR inhibitor attenuates greatly
renal cyst formation suggests that renal cyst formation might serve as a valuable
model system to explore the effects of CFTR modulators.
Supported by: This work was supported by the NKRF and CF Trust (UK) and FCT
(Portugal).
69 Activation of chloride secretion in human airway epithelial cells
by a new pyrrolo[2,3-b]pyrazine
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CFTR is expressed at apical membrane of airway epithelial cells and plays a pivotal
role in regulation of volume and composition of airway surface liquid. CFTR
defect causing cystic ﬁbrosis, development of CFTR pharmacological activators
is an important challenge for protein therapy.
Among a library of 6-phenylpyrrolo[2,3-b]pyrazines, we report the impact of
the substitution of 4-hydroxyphenyl (RP107) by 2-ﬂuorophenyl (RP193). EC50
of compounds, performed by iodide efﬂux experiments on CHO-CFTRwt cell
line with 1mM forskolin, shows a comparable afﬁnity: 110±1nM for RP193
vs. 152±1.2 nM for RP107. Patch clamp experiments reveal linear and time
independent chloride current elicited by RP193, and fully blocked by the CFTR
inhibitors: 2′-deoxyadenosine-methylglyoxal adducts (100pM) and CFTRinh-172
(10mM). We tested RP193 on primary culture of human bronchial epithelial cells
(HBEC), a more realistic model of airway epithelium. Non-CF lungs fragments were
obtained from patients who underwent lobectomy for lung cancer. Human bronchi
were dissected free of lung parenchyma. HBEC were harvested using enzymatic
isolation procedures, seeded on permeable membrane collagen and grown at air-
liquid interface. Cultures were mounted in Ussing chambers and baseline short
circuit current (Isc) was measured. In presence of amiloride 10mM and forskolin
1mM, sequential addition of RP193 (1 to 60mM) induce an increase in Isc. These
results demonstrate efﬁciency of RP193 on human CFTRwt chloride channel.
Supported by: VLM, ABCF, CNRS.
70 G622 amino acid has a crucial role in pharmacological activation
of CFTR chloride channel by benzo[c]quinolizinium compounds
A. Billet1, P. Melin1, C. Norez1, F. Bilan1, Y. Mettey1, F. Becq1. 1Institut de
physiologie et de biologie cellulaire, Universite´ de Poitiers, CNRS, Poitiers, France
To explore the mechanism of action of benzo[c]quinolizinium compound, the
potent activator 5-butyl-6-hydroxy-10-chlorobenzo[c]quinolizinium chloride (MPB-
91, Derand et al., 2001) was tested on CFTR-G622D (CF mutation) and CFTR-
E621D/G.
Site directed mutagenesis on GFP-CFTR-wt was used to obtain CFTR variants:
G622D, E621D and E621G. Patch-clamp experiments, in whole cell conﬁguration,
were performed on Cos-7 transiently transfected to examine CFTR chloride channel
activity. As GFP-CFTR-wt, the three mutants Cl− channels elicit a time and voltage
independent current in presence of 10mM Fsk and are blocked by 10mM of
CFTRinh-172. Ratio of global conductance (G) GFsk/Gbasal of GFP-CFTR-G622D
is 1.7 fold less than GFP-CFTR-wt [respectively 1.92±0.15 (n = 13) and 3.23±0.43
(n = 12)]. Western blot analysis shows a diminished trafﬁcking of CFTR-G622D
proteins. As expected, GFP-CFTR-wt channels are stimulated by 100mM of MPB-
91. Interestingly, activation of E621D and E621G but not of G622D channels is
recorded in presence of MPB-91.
Our study shows: (1) G622D, E621D and E621G CFTR channels are functional and
global conductance of G622D channels is reduced; (2) G622D proteins show an
altered trafﬁcking which could explain the weaker cAMP Cl− currents; (3) G622D
channels are refractory to benzo[c]quinolizinium activation.
The neutral amino acid G622 is well conserved in CFTR sequence of many species
and among the ABC transporter family (Callebaut et al., 2004). Our ﬁndings suggest
that G622 has a crucial role in pharmacological activation of CFTR by MPBs and
in the direct interaction of the compound with the channel.
Supported by: VLM, ABCF and CNRS.
71 Ezrin and cAMP/PKA have different compartmentalization in
CFBE41o- and 16HBE14o- cells
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NHERF1 overexpression in CFBE41o- (CFBE) cells induces a signiﬁcant increase
of both apical membrane deltaF508CFTR expression and of PKA-dependent acti-
vation of chloride efﬂux. We hypothesize that this NHERF1-dependent rescue of
deltaF508CFTR chloride secretion could be driven by the interaction of the actin
cytoskeleton with the ezrin-NHERF1-CFTR multiprotein complex. As NHERF1
binds only active ezrin, we analyzed the distribution of active P-T567-ezrin with
respect to total ezrin in both cell lines. In differential detergent extraction the ratio
of active to total ezrin was lower in CFBE with respect to 16HBE14o- (HBE) cells.
Confocal analysis demonstrated that active phospho-ezrin is localized at the apical
membrane in HBE while being mislocalized to the basolateral membrane in CFBE
cells. As ezrin is also an AKAP (A-kinase anchoring protein) protein involved
in PKA compartmentalization in the vicinity of CFTR protein, we investigated
the compartmentalization of cAMP and PKA. Confocal analysis demonstrated that
PKA is localized at the apical membrane in HBE cells while being cytoplasmic in
CFBE cells. Further, FRET (Fluorescence Resonance Energy Transfer) analysis
showed that cAMP is localized in the membrane regions of HBE cells while
being cytoplasmic in CFBE cells. These data show that in CFBE cells the known
altered deltaF508CFTR localization is associated with a mislocalization of the signal
transduction molecules involved in its activation, suggesting that the trafﬁcking
defect in CF cells includes its multiprotein regulatory complex (deltaF508CFTR-
NHERF1-actin-ezrin-PKA).
Supported by: FFC Italy.
